Additionally, strong EGFR expression was associated with reduced survival in WHO grade II oligodendrogliomas, but was a favorable marker for survival in WHO grade III anaplastic oligodendrogliomas (Horbinski et al., 2011). This evidence concerns the gene EGFR and oligodendroglioma.